Nordea Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.94M Sell
228,125
-9,520
-4% -$228K ﹤0.01% 587
2025
Q4
$6.35M Sell
237,645
-42,663
-15% -$1.02M 0.01% 535
2025
Q3
$5.91M Buy
280,308
+2,608
+0.9% +$61.7K 0.01% 558
2025
Q2
$6.11M Buy
277,700
+2,633
+1% +$48.9K 0.01% 527
2025
Q1
$4.57M Buy
275,067
+11,036
+4% +$200K ﹤0.01% 550
2024
Q4
$4.95M Buy
264,031
+3,516
+1% +$56.7K 0.01% 538
2024
Q3
$4.06M Sell
260,515
-14,970
-5% -$250K ﹤0.01% 568
2024
Q2
$4.45M Sell
275,485
-47,019
-15% -$759K 0.01% 547
2024
Q1
$5.94M Sell
322,504
-263,498
-45% -$6.53M 0.01% 511
2023
Q4
$18.5M Sell
586,002
-12,401
-2% -$296K 0.02% 333
2023
Q3
$12.5M Sell
598,403
-175
-0% -$4.75K 0.02% 347
2023
Q2
$14.5M Buy
598,578
+17,264
+3% +$384K 0.02% 346
2023
Q1
$11M Sell
581,314
-33,173
-5% -$632K 0.02% 362
2022
Q4
$9.76M Sell
614,487
-11,077
-2% -$173K 0.02% 380
2022
Q3
$10.2M Sell
625,564
-4,516
-0.7% -$73.1K 0.02% 364
2022
Q2
$8.89M Buy
630,080
+10,555
+2% +$197K 0.01% 392
2022
Q1
$15M Buy
619,525
+8,766
+1% +$212K 0.02% 339
2021
Q4
$14.2M Sell
610,759
-4,872
-0.8% -$98K 0.02% 354
2021
Q3
$10.3M Buy
615,631
+155,819
+34% +$3M 0.01% 398
2021
Q2
$11.2M Buy
459,812
+444,722
+2,947% +$10M 0.02% 373
2021
Q1
$400K Buy
+15,090
New +$664K ﹤0.01% 931
2019
Q2
Sell
-1,000
Closed -$27K 976
2019
Q1
$27K Hold
1,000
﹤0.01% 1226
2018
Q4
$16K Buy
+1,000
New +$19.4K ﹤0.01% 1233

Other funds holding ACAD